3-(4-Chlorophenoxy)pyrrolidine → N-(2-{3-[3-(4-Chlorophenoxy)-1-pyrrolidinyl]-2-hydroxy-2-methylpropoxy}phenyl)acetamide Hydrochloride

HRID 584625노트

반응식

HRID 584625 반응식
[CH3:1][C:2]1([CH2:5][O:6][C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][C:8]=2[NH:13][C:14](=[O:16])[CH3:15])[CH2:4][O:3]1.[Cl:17][C:18]1[CH:29]=[CH:28][C:21]([O:22][CH:23]2[CH2:27][CH2:26][NH:25][CH2:24]2)=[CH:20][CH:19]=1>>[ClH:17].[Cl:17][C:18]1[CH:29]=[CH:28][C:21]([O:22][CH:23]2[CH2:27][CH2:26][N:25]([CH2:4][C:2]([OH:3])([CH3:1])[CH2:5][O:6][C:7]3[CH:12]=[CH:11][CH:10]=[CH:9][C:8]=3[NH:13][C:14](=[O:16])[CH3:15])[CH2:24]2)=[CH:20][CH:19]=1

참가 물질

3

실험 절차

The title compound (255 mg, 110%) was prepared from N-{2-[(2-methyl-2-oxiranyl)methoxy]phenyl}acetamide (123 mg, 0.557 mmol) and 3-(4-chlorophenoxy)pyrrolidine (100 mg, 0.506 mmol) analogously to that described in Example 1 (iii).

출처 및 근거

ORD 기록
ord-3c461cfc135b48809017cf98bb48bf52
출처 데이터셋
uspto-grants-2005_08
특허 번호
US06927222B2

반응 노트

불러오는 중…